ARCHIVES

NCI Relates FDA Instructions On Latest IND Delays

This article is from The Cancer Letter archive.

Vol. 02 No. 44 | October 29, 1976

Download PDF Visit The Full Archive

Related Articles

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

November 6, 1981

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014

Conte Institute Leafs Scientific Effort On Central Europe Environmental Clean-Up

March 19, 1993

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

July 27, 2012